Keyphrases
Systemic Sclerosis
100%
Amyotrophic Lateral Sclerosis
55%
Scleroderma
53%
Fibrosis
35%
Glioblastoma
25%
Fibroblasts
23%
Randomized Controlled Trial
21%
Physical Activity
21%
Atopic Dermatitis
20%
Targeted Therapy
18%
Technology Support
17%
Physical Activity Intervention
17%
Interstitial Lung Disease
16%
Magnetic Resonance Imaging
15%
Toll-like
14%
Postcranium
14%
Radioembolization
14%
Modified Rodnan Skin Score (mRSS)
14%
Smoking Cessation
13%
Therapeutic Potential
13%
Moderate-to-vigorous Physical Activity
12%
Transforming Growth Factor-β
11%
Lung
11%
Randomized Trial
11%
Quitline
11%
Gene Signature
11%
Molecular Mechanism
11%
Tumor-associated Macrophages
11%
Fibroblast Activation
11%
Locomotor
11%
Primates
11%
Catenin
10%
United States
10%
Weight Management
10%
Tumor
10%
Fibrotic Response
10%
Health Behavior
9%
Metastatic Breast Cancer
9%
Neurodegeneration
9%
Parkinson's Disease
9%
TMEM230
9%
Randomized Placebo-controlled Trial
9%
Tumor Angiogenesis
9%
Intervention Studies
9%
MHealth Intervention
9%
Persistent Atrial Fibrillation
9%
Mitochondrial Uncoupling
9%
Snf1
9%
Mitochondrial Efficiency
9%
Eosinophils
9%
Allometry
9%
Pygmies
9%
Lifestyle Intervention
9%
Abstinence
9%
Smokers
9%
Skin Fibrosis
8%
Microglia
8%
Gene Expression
8%
Mycophenolate Mofetil
8%
Superoxide Dismutase 1 (SOD1)
8%
Inflammation
8%
Mobility Impairment
8%
Postcranial Morphology
8%
Profibrotic
8%
Overall Survival
8%
Toll-like Receptor 4 (TLR4)
7%
Innate Immune Signaling
7%
Skin Diseases
7%
E-health
7%
Patient-Reported Outcomes Measurement Information System (PROMIS)
7%
Yttrium-90 Radioembolization
7%
Immunosuppression
7%
Health-related Quality of Life
7%
Quadruped
7%
Femur
7%
Prosimian
7%
Cellular Mechanisms
7%
Video Camera
7%
Eating
7%
African Pygmies
7%
Placebo
7%
MHealth
7%
Sedentary Behavior
7%
Macrophages
6%
Genetic Studies
6%
Immune Response
6%
Immunosuppressive Microenvironment
6%
Pulmonary Function Test
6%
Adiponectin
6%
Healthy Lifestyle Intervention
6%
Triple-negative Breast Cancer
6%
Molecular Targets
6%
Stemness
6%
Itch
6%
Tumor Immunity
6%
Weight Gain
6%
Body Size
6%
Therapeutic Target
6%
Murine Model
6%
Molecular Pathways
6%
Medicine and Dentistry
Systemic Scleroderma
61%
Fibrosis
29%
Scleroderma
28%
Amyotrophic Lateral Sclerosis
19%
Fibroblast
19%
Diseases
18%
Neoplasm
18%
Magnetic Resonance Imaging
14%
Glioblastoma
14%
Radioembolization
14%
Hepatocellular Carcinoma
14%
Lung
14%
Targeted Therapy
14%
Phosphotransferase
13%
Toll Like Receptor 4
12%
Randomized Controlled Trial
12%
Skin Fibrosis
12%
Cardiovascular Disease
10%
Drive
10%
High Risk Behavior
10%
Cross Sectional Study
10%
Health Behavior
9%
Ovarian Cancer
9%
Intervention Trial
9%
e-Health
9%
Persistent Atrial Fibrillation
9%
Electrography
9%
Nicotine Withdrawal
9%
Physical Activity
9%
Quality of Life
9%
Overall Survival
8%
Placebo
8%
Clinical Trial
8%
Gene Expression
8%
Abstinence
8%
Weight Management
8%
Yttrium 90
7%
Toll Like Receptor
7%
Myofibroblast
7%
Malignant Neoplasm
6%
Lifestyle Intervention
6%
Tumor Microenvironment
6%
Cancer Cell
6%
Patient-Reported Outcome
6%
Body Mass Index
6%
Mobile Health
6%
Immunosuppressive Drug
6%
Health Assessment Questionnaire
6%
Outcome Assessment
6%
Cancer Growth Factor
5%
Hypothyroidism
5%
Thyroid Cancer
5%
Diabetes
5%
Chronic Disease
5%
Recurrent Disease
5%
Cellular Mechanism
5%
Lung Function Test
5%
Epithelial Cell
5%
Atopic Dermatitis
5%
Comorbidity
5%
Functional Assessment
5%
Extracellular Matrix
5%
Counseling
5%